<SEC-DOCUMENT>0001104659-21-133653-index.html : 20211103
<SEC-HEADER>0001104659-21-133653.hdr.sgml : 20211103
<ACCEPTANCE-DATETIME>20211103161606
ACCESSION NUMBER:		0001104659-21-133653
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20211102
FILED AS OF DATE:		20211103
DATE AS OF CHANGE:		20211103

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Cheng Andrew
		CENTRAL INDEX KEY:			0001778307

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38944
		FILM NUMBER:		211375576

	MAIL ADDRESS:	
		STREET 1:		170 HARBOR WAY, 3RD FLOOR
		STREET 2:		C/O AKERO THERAPEUTICS, INC.
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akero Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001744659
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-487-6488

	MAIL ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2131800-2_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2131800-2_4seq1.html

Document 1 - RAW XML: tm2131800-2_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>